Pfizer sees Covid-19 drug sales topping $50 bn in 2022
NEW YORK, Feb 9, 2022 (BSS/AFP) - Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and
Source: bssnews.net
Page 7 - Executive Albert Bourla News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Executive Albert Bourla. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Executive Albert Bourla Today - Breaking & Trending Today
Pfizer sees Covid-19 drug sales topping $50bn in 2022
NEW YORK - Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation.
Source: bangkokpost.com
Pfizer's 2021 profits doubled to $22 bn on strong Covid vaccine sales
Pfizer said Tuesday it expects $32 billion in revenue from Covid-19 vaccines in 2022 as it reported annual profits had more than doubled to $22 billion.
Source: rfi.fr
Pfizer's 2021 profits doubled to $22 bn on strong Covid vaccine sales
New York, United States Feb 8-Pfizer said Tuesday it expects $32 billion in revenue from Covid-19 vaccines in 2022 as it reported annual profits had more Kenya breaking news | Kenya news today |
Source: capitalfm.co.ke
Pfizer's 2021 profits doubled to $22 bn on strong COVID vaccine sales
The pharmaceutical giant, which with German company BioNTech won approval for the first vaccine to counter the deadly virus, saw annual revenues nearly double to $81.3 billion, with $36.8 billion from the COVID-19 vaccine.
Source: ewn.co.za